Click to scroll back to the top
Share on Facebook
Share on Twitter
Share on Linkedin
Click to go to previous articleClick to go to next article
Close.svg
result
Spotlight
People
Houston Methodist is committed to attracting highly talented leaders, scientists, innovators and teachers. We are pleased to introduce those who have joined our organization since early 2020.
dm_Spotlight_400x532_CA.jpg
Cesar Arias, MD, PhD
Department of Medicine & the Center for Infectious Diseases. Chief of Infectious Diseases at Houston Methodist Hospital and co-director of the Center for Infectious Diseases Research at Houston Methodist Research Institute and Weill Cornell Medical College, Previously, University of Texas Health Science Center at Houston (UTHealth). Founder, Center of Antimicrobial Resistance and Microbial Genomics (CARMiG) at McGovern Medical School. Editor in Chief of ASM’s Antimicrobial Agents and Chemotherapy.associate director, Cardiovascular Disease Prevention Research, Department of Cardiology, DeBakey Heart & Vascular Center, joined Houston Methodist in May 2020. He formerly worked at the Cicccarone Center for the Prevention of Cardiovascular Disease at Johns Hopkins Medicine, where he served as a preventive cardiologist, epidemiologist, population health expert, and outcomes and data scientist.
Dr-Amy-Waterman-6279.jpeg
Amy Waterman, PhD
Department of Surgery as the Director of Patient Engagement, Diversity & Education, Division Chief for Patient Engagement and Diversity for the Center for Outcomes Research Previously, Professor in Residence, Division of Nephrology, David Geffen School of Medicine at UCLA. Senior Quality Consultant, UCLA Kidney Transplant Program. Deputy Director of the Terasaki Institute for Biomedical Innovation.
Rodney Folz, MD, PhD
Department of Medicine as the Pulmonary Division Chief Previously, Chief of Pulmonary Critical Care and Sleep Medicine at Cleveland Medical Center. Visiting Professor at Case Western Reserve School of Medicine.
Amanda Arrington, MD, MHM, FSSO, FACS
Associate Professor, Surgical Oncology. Director, HIPEC Program. Previously, Associate Professor of Surgery, Vice Chair for Community Outreach, Associate Program Director, ACES ADV GI/MIS Clinical Fellowship at the University of Arizona College of Medicine.
Chih-Chi Andrew Hu, PhD
Center for Translational Research in Hematological Malignancies, Professor of Oncology Previously, professor in the Immunology, Microenvironment & Metastasis Program, Wistar Institute Cancer Center, Philadelphia; professor, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania.
Zhonglin Liu, MD
Department of Radiology, PET Imaging Core Previously, Research Professor of Medical Imaging, Clinical and Translational Oncology Program, Cancer Center, University of Arizona.
Diego R. Martin, MD, PhD, FRCPC
Chair and Professor of the Department of Radiology Previously, chair of the Department of Diagnostic Radiology, McGill University, Montreal; Chair of the Medical Imaging Department at the University of Arizona. Current chair and director of Education for Body MRI at the American College of Radiology Learning Center and the Continuous Professional Improvement Program.
Joan Nichols, PhD
Scientist, Houson Methodist Research Institute Previously, University of Texas Medical Branch at Galveston; affiliate appointment at Houston Methodist Research Institute since 2015.
Chih-Hang Anthony Tang, MD, PhD
Assistant Professor of Oncology, Center for Translational Research in Hematological Malignancies at Houston Methodist Cancer Center Previously, Staff Scientist in the Immunology, Microenvironment & Metastasis Program at the Wistar Institute.
Jing Yang, PhD
Center for Translational Research in Hematological Malignancies, Associate Professor of Oncology Previously, associate professor, UT MD Anderson Cancer Center, Department of Lymphoma and Myeloma. She joins Houston Methodist as a scientist in the Center for Translational Research in Hematological Malignancies.
Ming You, MD, PhD
Director, Center for Cancer Prevention, Cancer Center Previously, Joseph F. Heil Jr. Professor in Molecular Oncogenesis in the Department of Pharmacology and Toxicology, Associate Provost for Cancer research, Founding Director of the Disease Prevention research Center, Medical College of Wisconsin.
Miguel Cainzos-Achirica MD, PhD, MPH,
associate director, Cardiovascular Disease Prevention Research, Department of Cardiology, DeBakey Heart & Vascular Center, joined Houston Methodist in May 2020. He formerly worked at the Cicccarone Center for the Prevention of Cardiovascular Disease at Johns Hopkins Medicine, where he served as a preventive cardiologist, epidemiologist, population health expert, and outcomes and data scientist.
Francisco Altamirano, PhD,
joined the DeBakey Heart & Vascular Center in January 2020 as the director of the electrophysiology lab, Basic Sciences, in collaboration with Miguel Valderrábano, MD, Lois and Carl Davis Centennial Chair and professor of cardiology. Altamirano previously worked in cardiology at the University of Texas Southwestern Medical Center.
Masahiro Fujita, MD, PhD,
joined Houston Methodist in January 2020 as director of the positron emission tomography (PET), Translational Imaging Core, and chair of the radiation safety committee at the Research Institute. Fujita is an internationally recognized expert on brain molecular imaging using PET, with expertise in the evaluation of PET tracers and kinetic analysis of brain PET. He aims to guide the development of novel therapies by bridging expertise in basic and clinical sciences. Fujita earned an MD and PhD from Osaka University, Japan, in 1987 and 1992, respectively. In Japan, he earned board certification in nuclear medicine and diagnostic radiology and also obtained qualification as a Type-1 Radiation Protection Supervisor. He previously held positions as a staff scientist at the National Institute of Mental Health from 2002 to 2018 and assistant professor at Yale University from 1999 to 2002.
Charles E. Geyer, Jr., MD, FACP,
joined joined Houston Methodist in January 2020 as deputy director of the Houston Methodist Cancer Center. He has devoted his academic career to the design and conduct of multi-institutional, phase 3 clinical trials in breast cancer with a focus on HER2 targeted therapies. Currently he is co-chair of the NRG Breast Committee and chair of the NSABP Foundation Breast Cancer Committee. Geyer served as study PI on the practice-changing KATHERINE trial and has co-authored over 80 peer-reviewed manuscripts including results of several landmark phase 3 trials conducted by the NSABP.
Farhaan Vahidy, MBBS, PhD, MPH,
joined the Center for Outcomes Research (COR) in January 2020 as associate director and the division chief of Population Health Science & Health Services Research. He will lead the development of learning health care systems models utilizing artificial intelligence and machine learning for rapid integration of scientifically robust evidence into health care practice. He will serve as a key leader at the COR, participating in strategic planning, implementation and mentoring COR’s scientists and research staff. Vahidy was previously an associate professor of neurology at the McGovern Medical School (UTHealth) where he directed the Data Management and Analysis Core and the Division of Population Health and Health Services Research for UTHealth's Institute for Stroke and Cerebrovascular Diseases.
Follow us
Copyright 2022. Houston Methodist, Houston, TX. All rights reserved.
Share this story